X

Thank you for sharing!

Your article was successfully shared with the contacts you provided.

A federal court invalidated the patent for a blockbuster osteoporosis drug made by Merck & Co. on Friday, sending Merck shares plunging but offering patients with the brittle-bone disease the possibility of cheaper pills in a few years.

This premium content is locked for
Law.com subscribers only.

*May exclude premium content
Already have an account?
Interested in customizing your subscription with Law.com All Access?
Contact our Sales Professionals at 1-855-808-4530 or send an email to groupsales@alm.com to learn more.

 

ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2019 ALM Media Properties, LLC. All Rights Reserved.